Copeland Capital Management
LMAT icon

Copeland Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Copeland Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.3M Buy
924,081
+84,618
+10% +$7.49M 1.76% 4
2026
Q2 		$80.6M Sell
839,463
-31,229
-4% -$3.2M 1.65% 11
2026
Q1 		$95.1M Sell
870,692
-18,285
-2% -$1.74M 2.11% 3
2025
Q4 		$72.1M Sell
888,977
-51,351
-5% -$4.42M 1.61% 11
2025
Q3 		$82.3M Sell
940,328
-49,709
-5% -$4.44M 1.71% 5
2025
Q2 		$82.2M Sell
990,037
-88,686
-8% -$7.41M 1.69% 6
2025
Q1 		$90.5M Sell
1,078,723
-93,292
-8% -$8.68M 1.81% 7
2024
Q4 		$108M Buy
1,172,015
+8,623
+0.7% +$829K 2.01% 4
2024
Q3 		$108M Buy
1,163,392
+11,318
+1% +$981K 1.88% 4
2024
Q2 		$94.8M Sell
1,152,074
-138,819
-11% -$10.2M 1.77% 8
2024
Q1 		$85.7M Buy
1,290,893
+30,932
+2% +$1.91M 1.56% 13
2023
Q4 		$71.5M Buy
1,259,961
+28,720
+2% +$1.5M 1.43% 20
2023
Q3 		$67.1M Buy
1,231,241
+5,515
+0.4% +$327K 1.44% 22
2023
Q2 		$82.5M Sell
1,225,726
-139,016
-10% -$8.48M 1.7% 7
2023
Q1 		$70.2M Buy
1,364,742
+87,264
+7% +$4.24M 1.65% 12
2022
Q4 		$58.8M Buy
1,277,478
+53,896
+4% +$2.52M 1.55% 16
2022
Q3 		$62M Buy
1,223,582
+11,276
+0.9% +$563K 2.05% 4
2022
Q2 		$55.2M Sell
1,212,306
-2,699
-0.2% -$121K 1.75% 8
2022
Q1 		$56.5M Buy
1,215,005
+9,806
+0.8% +$439K 1.56% 13
2021
Q4 		$60.5M Buy
1,205,199
+80,112
+7% +$4.14M 1.57% 13
2021
Q3 		$59.7M Buy
1,125,087
+62,054
+6% +$3.5M 1.7% 5
2021
Q2 		$64.9M Buy
1,063,033
+171,708
+19% +$9.12M 1.95% 5
2021
Q1 		$43.5M Sell
891,325
-60,170
-6% -$2.82M 1.35% 36
2020
Q4 		$38.5M Buy
951,495
+63,577
+7% +$2.27M 1.52% 25
2020
Q3 		$28.9M Buy
887,918
+221,953
+33% +$6.66M 1.28% 38
2020
Q2 		$17.6M Buy
665,965
+24,917
+4% +$651K 0.91% 48
2020
Q1 		$16M Buy
641,048
+79,975
+14% +$2.47M 0.97% 43
2019
Q4 		$20.2M Buy
561,073
+20,588
+4% +$710K 0.88% 47
2019
Q3 		$18.5M Buy
540,485
+152,753
+39% +$4.88M 0.95% 42
2019
Q2 		$10.8M Buy
387,732
+209,913
+118% +$5.83M 0.6% 59
2019
Q1 		$5.51M Buy
177,819
+177,086
+24,159% +$4.73M 0.35% 77
2018
Q4 		$17K Buy
+733
New +$20K ﹤0.01% 163

Other funds holding LMAT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Conestoga Capital Advisors
Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Geneva Capital Management
Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Copeland Capital Management's LMAT Position: Q3 2026 in Review

Copeland Capital Management increased its LeMaitre Vascular (LMAT) stake by 10% in Q3 2026, buying an estimated $7.49M and bringing the position to 924,081 shares worth $76.3M. The position accounts for 1.76% of the portfolio, ranked #4.

Copeland Capital Management first reported a position in LMAT in Q4 2018 and has held it in 32 quarters since. The position peaked at $108M in Q3 2024. 164 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Copeland Capital Management held 924,081 shares of LeMaitre Vascular worth $76.3M as of Q3 2026.
  • Copeland Capital Management bought 84,618 LeMaitre Vascular shares in Q3 2026, an estimated $7.49M.
  • LeMaitre Vascular made up 1.76% of Copeland Capital Management's portfolio in Q3 2026, its #4 holding.
  • Copeland Capital Management first reported a position in LeMaitre Vascular in Q4 2018 and has held it in 32 quarters since.
  • Copeland Capital Management's LeMaitre Vascular position peaked at $108M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Copeland Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.